https://www.immunosabr.org/h2020-grant/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/kick-off-meeting-presentation/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/cro/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/presentation-utrecht/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/presentation-barcelona/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/new-participant/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/new-data/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/amendment-eu-periodic-report-ready-for-submission/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/presentation-liverpool-uk/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/presentation-new-york/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/presentation-paris/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/presentation-brussels-roma/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/new-immunosabr-website-launched/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/annual-immunosabr-meeting-2019/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/metc-approval/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/first-patients-enrolled-in-immuosabr-clinical-trial/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/eight-patients-are-now-enrolled-in-the-immuosabr-clinical-trial/ 2020-10-04T18:50:50+00:00 monthly 0.2 https://www.immunosabr.org/maastricht-umc/ 2020-10-08T17:20:46+00:00 monthly 0.2 https://www.immunosabr.org/dtu/ 2020-10-08T17:20:26+00:00 monthly 0.2 https://www.immunosabr.org/ecpc/ 2020-10-08T17:19:48+00:00 monthly 0.2 https://www.immunosabr.org/kuleuven/ 2020-10-08T17:19:18+00:00 monthly 0.2 https://www.immunosabr.org/ucsc/ 2020-10-08T17:18:47+00:00 monthly 0.2 https://www.immunosabr.org/nki-avl/ 2020-10-08T17:18:22+00:00 monthly 0.2 https://www.immunosabr.org/universitair-ziekenhuis-gent/ 2020-10-08T17:18:01+00:00 monthly 0.2 https://www.immunosabr.org/the-cliniques-universitaires-saint-luc/ 2020-10-08T17:17:39+00:00 monthly 0.2 https://www.immunosabr.org/centre-oscar-lambret/ 2020-10-08T17:17:19+00:00 monthly 0.2 https://www.immunosabr.org/universitaets-klinikum-tuebingen/ 2020-10-08T17:17:00+00:00 monthly 0.2 https://www.immunosabr.org/university-college-london/ 2020-10-08T17:16:27+00:00 monthly 0.2 https://www.immunosabr.org/technische-universita%cc%88t-dresden/ 2020-10-08T17:16:01+00:00 monthly 0.2 https://www.immunosabr.org/radboudumc/ 2020-10-08T17:15:36+00:00 monthly 0.2 https://www.immunosabr.org/philogen-s-p-a/ 2020-10-08T17:13:03+00:00 monthly 0.2 https://www.immunosabr.org/health-innovation-ventures-b-v/ 2020-10-08T17:15:01+00:00 monthly 0.2 https://www.immunosabr.org/heidelberg-university-hospital/ 2020-12-02T23:40:24+00:00 monthly 0.2 https://www.immunosabr.org/institut-regional-du-cancer-montpellier/ 2020-12-02T23:43:41+00:00 monthly 0.2 https://www.immunosabr.org/gasthuiszusters-antwerpen/ 2020-12-02T23:47:21+00:00 monthly 0.2 https://www.immunosabr.org/erasmus-mc/ 2020-12-02T23:48:47+00:00 monthly 0.2 https://www.immunosabr.org/june-2022-newsletter/ 2024-05-12T21:22:55+00:00 monthly 0.2 https://www.immunosabr.org/september-2022-newsletter/ 2024-05-12T21:26:04+00:00 monthly 0.2 https://www.immunosabr.org/december-2022-newsletter/ 2024-05-12T21:27:53+00:00 monthly 0.2 https://www.immunosabr.org/march-2023-newsletter/ 2024-05-12T21:31:39+00:00 monthly 0.2 https://www.immunosabr.org/a-model-to-calculate-uncertainty-of-radiomics-analysis-developped-during-immunosabr-has-been-applied-to-head-and-neck-cancer/ 2024-11-24T21:48:00+00:00 monthly 0.2 https://www.immunosabr.org/an-interpretable-model-of-radiomics-analysis-developped-during-immunosabr-has-been-applied-to-elastography-of-the-liver/ 2024-11-24T22:04:08+00:00 monthly 0.2 https://www.immunosabr.org/recruitment-for-the-randomized-phase-2-trial-immunosabr-has-concluded-with-a-total-of-88-patients-included-44-in-control-arm-and-44-in-experimental-arm/ 2024-11-24T22:03:55+00:00 monthly 0.2 https://www.immunosabr.org/all-biomaterials-have-been-successfully-transferred-from-the-11-participating-centers-to-the-maastricht-central-biobank/ 2024-11-24T22:03:43+00:00 monthly 0.2 https://www.immunosabr.org/we-have-established-an-agreement-with-ku-leuven-to-analyze-immunological-serum-biomarkers-in-blood-samples-from-patients-enrolled-in-immunosabr/ 2024-11-24T22:03:34+00:00 monthly 0.2 https://www.immunosabr.org/collaboration-with-a-bioinformatician-from-maastricht-university-medical-centre-mumc/ 2024-11-24T21:57:56+00:00 monthly 0.2 https://www.immunosabr.org/we-recently-signed-an-agreement-with-the-company-qualiblood-to-analyze-blood-samples-from-patients-enrolled-in-immunosabr/ 2024-11-24T21:59:00+00:00 monthly 0.2 https://www.immunosabr.org/we-have-established-a-contract-with-company-baseclear-for-microbiome-analysis-of-the-collected-samples-both-control-arm-and-experimental-arm/ 2024-11-24T22:00:14+00:00 monthly 0.2 https://www.immunosabr.org/we-are-currently-in-discussions-with-the-company-ingedata-to-segment-lesions-in-imaging-data-from-patients-in-the-immunosarbor-trial/ 2024-11-24T22:01:31+00:00 monthly 0.2 https://www.immunosabr.org/on-site-monitoring-for-the-immunosabr-project-has-officially-started/ 2024-11-24T22:02:24+00:00 monthly 0.2 https://www.immunosabr.org/a-new-student-assistant-feline-geels-has-joined-our-team/ 2024-11-24T21:56:37+00:00 monthly 0.2